HONG KONG – In a move to improve its drug manufacturing, research and development capacity as well as to strengthen its international presence, Shanghai Fosun Pharmaceutical (Group) Co. Ltd. made an offer to acquire a 96 percent stake in Indian drugmaker Gland Pharma Ltd.
